
A global leader in fermentation-based non-beta-lactam anti-infectives
Xellia Pharmaceuticals manufactures and commercializes essential anti-infective active pharmaceutical ingredients (APIs) for serious and often life-threatening conditions.
Xellia Pharmaceuticals is a global leader in fermentation-based non-beta-lactam anti-infectives. We manufacture and supply APIs as well as Finished Dosage Forms (FDFs) to over 500 pharmaceutical companies across 80 countries.
The World Health Organization and the European Union recognize a variety of our products as essential and critical medicines, serving as crucial resources in the fight against severe infections and antimicrobial resistance.
Headquartered in Copenhagen, Denmark, Xellia Pharmaceuticals boasts a global footprint, with manufacturing sites in Denmark, Hungary, and China, alongside R&D and commercial operations in an additional eight locations around the world. We stand as the sole European manufacturer of several of our products and possess a rich legacy of over 120 years in the pharmaceutical industry.

APIs and FDFs
Our products
Check out a list of active pharmaceutical ingredients (APIs) and Finished Dosage Forms (FDFs) we offer

Press releases and news archive
Latest news
Today, we launch a new website and refreshed visual identity for Xellia. This is more than just a new design. It is a reflection of who we are today